Brief: Neuren Pharmaceuticals Announces New On-Market Share Buy-Back Program
11/02/2026 08:16
Feb 11 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX: ANNOUNCES NEW ON-MARKET SHARE BUY-BACK PROGRAM BUY-BACK PROGRAM WILL NOT EXCEED 5% OF TOTAL SHARES ON ISSUE 12 MONTHS PRIOR TO COMMENCEMENT OF BUY- BACK Further company coverage: NEU.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuren Pharmaceuticals
See all newsAustralia's Neuren set for weekly gain on FDA nod, drug forecast upgrade
Australia's Neuren Pharmaceuticals gains on upbeat FY trofinetide earnings outlook
Australia's Neuren Pharma rises as US FDA grants orphan tag for NNZ-2591
Strong partner sales propel Neuren Pharmaceuticals to top of Australia benchmark
Brief: Neuren Pharmaceuticals Says DAYBU Recommended For Approval In European Union